1 employees
Genoa Pharmaceuticals develops therapies for the treatment of idiopathic pulmonary fibrosis.
2011
$62M
from 4 investors over 4 rounds
Genoa Pharmaceuticals raised $62M on May 15, 2017
Investors: RiverVest Venture Partners, Novo Holdings, Andera Partners and F-Prime Capital Partners